Medical Devices Mexico

Mexico Left Atrial Appendage Closure Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Mexico Left Atrial Appendage Closure Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Mexico · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $29.2 Mn Placeholder estimate
Estimate 2025 $33.9 Mn 1.6% of the global market
Projected 2034 $132.1 Mn 289.2% Adds $98.2 Mn over 9 forecast years
CAGR 2025–2034 16.3% Faster than 89% of 173 Medical Devices markets here
Key players 5
  • Mexico is 1.58% of the global market.
  • In Latin America, the largest is Brazil at $56.0 Mn.
  • Fastest growing: Brazil at 17.3% a year.
  • Mexico ranks 3rd of 3 by size in Latin America.

Market size projection

Mexico

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$98.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Left Atrial Appendage Closure Market market size by year, Mexico
YearMarket sizeChange that yearSince 2025
2024 (estimate) $29.2 Mn — —
2025 (base) $33.9 Mn +$4.8 Mn —
2026 (forecast) $39.5 Mn +$5.5 Mn +16.3%
2027 (forecast) $45.9 Mn +$6.4 Mn +35.3%
2028 (forecast) $53.4 Mn +$7.5 Mn +57.3%
2029 (forecast) $62.1 Mn +$8.7 Mn +82.9%
2030 (forecast) $72.2 Mn +$10.1 Mn +112.8%
2031 (forecast) $84.0 Mn +$11.8 Mn +147.4%
2032 (forecast) $97.7 Mn +$13.7 Mn +187.8%
2033 (forecast) $113.6 Mn +$15.9 Mn +234.7%
2034 (forecast) $132.1 Mn +$18.5 Mn +289.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.15 Bn
  2. North America $1.08 Bn
  3. US $963.1 Mn
  4. Europe $414.1 Mn
  5. APAC $415.9 Mn
  6. Canada $185.9 Mn
  7. China $158.8 Mn
  8. Japan $132.5 Mn
  9. Latin America $90.7 Mn
  10. Middle East $80.2 Mn
  11. Germany $72.1 Mn
  12. UK $61.4 Mn
  13. Brazil $56.0 Mn
  14. Italy $52.9 Mn
  15. France $50.3 Mn
  16. India $46.4 Mn
  17. Saudi Arabia $40.2 Mn
  18. Spain $37.7 Mn
  19. Ecuador $37.2 Mn
  20. Mexico (this report) $33.9 Mn
  21. Africa $34.5 Mn
  22. New Zealand $24.1 Mn
  23. Australia $24.8 Mn
  24. Russia $18.5 Mn
  25. South Africa $15.9 Mn
  26. UAE $9.7 Mn
  27. Egypt $6.7 Mn
  28. Philippines $4.9 Mn
  29. Hong Kong $3.8 Mn
  30. Malaysia $3.6 Mn
  31. Singapore $3.0 Mn
  32. Thailand $2.6 Mn
  33. Kenya $1.6 Mn

Report snapshot

Mexico Left Atrial Appendage Closure Market Analysis at a glance
Market size, 2025$33.9 Mn placeholder estimate
Forecast, 2034$132.1 Mn placeholder estimate
Growth (CAGR), 2025–203416.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and end user (see all)
Key playersBoston Scientific Corporation, Abbott Laboratories, AtriCure, Inc, Conformal Medical, Lifetech Scientific (see all)
Regulator in MexicoCOFEPRISSource: COFEPRIS. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Mexico Left Atrial Appendage Closure Market Analysis Executive Summary

Left atrial appendage closure devices seal off a small pouch in the heart to lower stroke risk in people with atrial fibrillation.

Key segments of the left Atrial Appendage Closure market include product (Endocardial Devices and Epicardial Devices) and setting (Hospitals and Cardiac Centers).

Bar chart: Mexico Left Atrial Appendage Closure market size, 2024–2034, placeholder estimates. $29.2 Mn in 2024, $33.9 Mn in 2025 and $132.1 Mn in 2034, 16.3% CAGR.
Mexico Left Atrial Appendage Closure market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Mexico Left Atrial Appendage Closure Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the left Atrial Appendage Closure market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the left Atrial Appendage Closure market.

Competitive Landscape for Left Atrial Appendage Closure Market in Mexico

The left Atrial Appendage Closure market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Left Atrial Appendage Closure Market in Mexico

Left Atrial Appendage Closure in Mexico: rules, payment and health figures

Medical devices need a sanitary registration from COFEPRIS before sale.⁠[1] Public care comes through IMSS for formal workers, ISSSTE for public employees, and IMSS-Bienestar for people without social security.⁠[2] Early deaths from long-term diseases: 15.4% in 2023, the latest WHO figure for Mexico.⁠[3]

[1] COFEPRIS. Checked 14 Nov 2026.

[2] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how left Atrial Appendage Closure products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Mexico.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Left Atrial Appendage Closure right now, from free public sources.

Latest research 1,353 papers since 2021 (worldwide)

  1. ASAP-TOO Stopped Too Soon: Right Question, Enormous Effort, and an Incomplete Answer. Journal of the American College of Cardiology, 2026
  2. Left Atrial Appendage Closure in Patients Considered Unsuitable for Oral Anticoagulation: Randomized Outcomes Through 5 Years in ASAP-TOO. Journal of the American College of Cardiology, 2026
  3. Individual Participant Data Meta-Analyses of Left Atrial Appendage Closure Trials: The Needed Next Step to Inform Clinical Decision-Making. Journal of the American College of Cardiology, 2026
  4. Percutaneous Left Atrial Appendage Closure vs Anticoagulation: More Shared Decision-Making or More Randomized Data? Journal of the American College of Cardiology, 2026
  5. Left Atrial Appendage Closure in Atrial Fibrillation Patients With High Risk of Stroke and Bleeding: An Individual Participant Data Meta-Analysis of Randomized Trials. Journal of the American College of Cardiology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Left Atrial Appendage Closure in context

Mexico compared

  • Early deaths from long-term diseases: 15.4% (2023). World: 17.2% (2023). 2nd highest of the 4 countries we cover in Latin America.[1]
  • Health spending per person: 761 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 4 countries we cover in Latin America.[2]
  • Doctors: 2.59 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 4 countries we cover in Latin America.[3]

[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Left Atrial Appendage Closure market in Mexico?
Placeholder estimate: about $33.9 Mn in 2025, rising to about $132.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Left Atrial Appendage Closure market in Mexico growing?
Placeholder estimate: about 16.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Left Atrial Appendage Closure market report cover?
The report splits the market by product (Endocardial Devices, Epicardial Devices), setting (Hospitals, Cardiac Centers) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Left Atrial Appendage Closure market?
Key players include Boston Scientific Corporation, Abbott Laboratories, AtriCure, Inc, Conformal Medical and Lifetech Scientific.
What is driving the Left Atrial Appendage Closure market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.
Who regulates Left Atrial Appendage Closure in Mexico?
Medical devices need a sanitary registration from COFEPRIS before sale. Source: COFEPRIS. Checked 14 Nov 2026.
How is healthcare paid for in Mexico?
Public care comes through IMSS for formal workers, ISSSTE for public employees, and IMSS-Bienestar for people without social security. Source: Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
What does WHO report for Mexico?
Early deaths from long-term diseases: 15.4% in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
How many people in Mexico are 65 or older?
8.5% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
How much research is published on Left Atrial Appendage Closure?
PubMed lists 1,353 papers on Left Atrial Appendage Closure added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Left Atrial Appendage Closure in Mexico? Our analysts can size it for your plan. Talk to us See the public data Early deaths from long-term diseases (WHO) for every country, free. Open the Public Health Dashboard

From our blog

Omega-3: Heart, Brain and the Evidence DebateOmega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart. Angiography: Seeing Inside the Blood VesselsCardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in… Rehabilitation Equipment: Recovery Beyond the Hospital2.4 billion people live with a condition that could benefit from rehabilitation. The need rose 63% since 1990.
Back to Catalogue
Keep exploring

Related Medical Devices reports in Mexico

See all
Same topic, other categories

Related on cardiovascular and stroke

See the topic